Search - tctmd.com

Displaying 721 - 740 of 3013

Sort: Relevancy | Date

News Conference News TCT 2020

Fewer Events and Symptoms With iFR-Optimized PCI, Suggests DEFINE-PCI Trial

Michael O'Riordan

October 17, 2020

News Conference News TCT 2020

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

L.A. McKeown

October 17, 2020

Presentation TCT 2020

OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-Wire DES

Presenter: Dean Kereiakes

October 17, 2020

The OPTIMIZE IDE: TrialProspective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier

Presentation TCT 2020

OPTIMIZE IDE: Trial Prospective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier

Presenter: Dean J. Kereiakes

October 17, 2020

Presentation TCT 2020

COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Coated Stent With 14 Days DAPT in High-Bleeding Risk Patients

Presenter: Robert Byrne

October 17, 2020

Presentation TCT 2020

The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome

Presenter: Hyo-Soo Kim

October 17, 2020

Presentation TCT 2020

HOST-REDUCE-POLYTECH-ACS: A Randomized Trial of Durable Polymer vs Bioabsorbable Polymer DES in Patients With Acute Coronary Syndromes

Presenter: Hyo-Soo Kim

October 17, 2020

News Conference News TCT 2020

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Shelley Wood

October 17, 2020

Debate: What Should Be the Default Strategy for a True Left Main Bifurcation PCI? - Provisional Stenting Should Be the Gold Standard, and EBC-MAIN Will Prove It!

Presentation TCT 2020

Provisional Stenting Should Be the Gold Standard, and EBC-MAIN Will Prove It!

Presenter: David Hildick-Smith

October 17, 2020

Presentation TCT 2020

Debate: What Should Be the Default Strategy for a True Left Main Bifurcation PCI? - DK-Crush Outperforms Both Provisional and Culotte Stenting!

Presenter: Emmanouil Brilakis

October 17, 2020

News Conference News TCT 2020

FFR Insights Before and After PCI: Fresh Food for Thought

Caitlin E. Cox

October 16, 2020

Presentation TCT 2020

Coronary Stenting in High Bleeding Risk Patients: Is There a Preferred DES for Short DAPT?

Presenter: Davide Capodanno

October 15, 2020

Presentation TCT 2020

Stent Thrombosis: Is There a Standard Approach to Workup and Management?

Presenter: Robert Byrne

October 15, 2020

Presentation TCT 2020

In-Stent-Restenosis: Angioplasty With Drug-Coated Balloon or Repeat Stenting With DES – Which Treatment for Which Patient?

Presenter: Fernando Alfonso

October 15, 2020

News Conference News TCT 2020

IVUS-Guided PCI Gains Support With Longer-Term ULTIMATE Results

Todd Neale

October 15, 2020

News Conference News TCT 2020

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

Caitlin E. Cox

October 15, 2020

News Conference News TCT 2020

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

L.A. McKeown

October 15, 2020

News Conference News TCT 2020

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Shelley Wood

October 14, 2020

News Conference News TCT 2020

Delays, Deaths, and More Cardiogenic Shock Among ACS Patients With COVID-19

Todd Neale

October 14, 2020

News Conference News TCT 2020

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

Todd Neale

October 14, 2020

Advertisement

Fewer Events and Symptoms With iFR-Optimized PCI, Suggests DEFINE-PCI Trial

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-Wire DES

OPTIMIZE IDE: Trial Prospective, Randomized Evaluation of Sirolimus-Eluting Coronary Stents with Fixed-Wire and Rapid-Exchange Delivery Systems and a Novel Bioresorbable Drug Carrier

COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Coated Stent With 14 Days DAPT in High-Bleeding Risk Patients

The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome

HOST-REDUCE-POLYTECH-ACS: A Randomized Trial of Durable Polymer vs Bioabsorbable Polymer DES in Patients With Acute Coronary Syndromes

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Provisional Stenting Should Be the Gold Standard, and EBC-MAIN Will Prove It!

Debate: What Should Be the Default Strategy for a True Left Main Bifurcation PCI? - DK-Crush Outperforms Both Provisional and Culotte Stenting!

FFR Insights Before and After PCI: Fresh Food for Thought

Coronary Stenting in High Bleeding Risk Patients: Is There a Preferred DES for Short DAPT?

Stent Thrombosis: Is There a Standard Approach to Workup and Management?

In-Stent-Restenosis: Angioplasty With Drug-Coated Balloon or Repeat Stenting With DES – Which Treatment for Which Patient?

IVUS-Guided PCI Gains Support With Longer-Term ULTIMATE Results

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Delays, Deaths, and More Cardiogenic Shock Among ACS Patients With COVID-19

Ticagrelor Monotherapy Following 3-Month DAPT Cuts Post-PCI Bleeding After STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content